MCS in the Treatment of Lower Urinary Tract Symptoms
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The hypothesis of the study is to examine whether MCS-2 is safe and effective in the
treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.